Zobrazeno 1 - 10
of 71
pro vyhledávání: '"C K, Tashima"'
Publikováno v:
Archives of internal medicine. 139(9)
Diabetes insipidus, resulting from metastatic involvement of the neurohypophysial system, is a rare complication of breast cancer. This review examined the clinical features, metastatic pattern, and radiological and postmortem findings of 39 breast c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c208edd5083c360faea3d0e65babccf8
https://pubmed.ncbi.nlm.nih.gov/475518
https://pubmed.ncbi.nlm.nih.gov/475518
Autor:
C K, Tashima
Publikováno v:
Cancer chemotherapy reports. 58(5 Pt 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5dbf3a52bec686cea9bf609e34afba13
https://pubmed.ncbi.nlm.nih.gov/4426043
https://pubmed.ncbi.nlm.nih.gov/4426043
Autor:
M K, Ali, A, Soto, D, Maroongroge, S, Bekheit-Saad, A U, Buzdar, G R, Blumenschein, G N, Hortobagyi, C K, Tashima, C L, Wiseman, C C, Shullenberger
Publikováno v:
Cancer. 43(2)
The electrocardiograms of 146 patients with metastatic carcinoma of the breast were reviewed before, during, and after the patients received Adriamycin (Doxorubicin) chemotherapy (AD). The most significant electrocardiographic change occurred in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc78be60d0cac575bddfd8c16ae53b5a
https://pubmed.ncbi.nlm.nih.gov/421174
https://pubmed.ncbi.nlm.nih.gov/421174
Publikováno v:
JAMA. 243(17)
An analysis of 29 chemotherapeutic trials in 18 male patients with advanced breast cancer disclosed an overall response rate of 44%. Most of these chemotherapeutic trials consisted of single-agent regimens, namely, fluorouracil, methotrexate, thiotep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f618dfbf55ee927a67a477a1d0e57a4
https://pubmed.ncbi.nlm.nih.gov/7365938
https://pubmed.ncbi.nlm.nih.gov/7365938
Publikováno v:
Cancer. 44(1)
Bone marrow involvement by breast carcinoma in the absence of demonstrable bone lesions is unusual. We report six patients with medullary tumor without demonstration of cortical bone abnormality on scan or radiographs. This represents 2.8% of 213 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d32295bfa73a474ffd84f4844b54a577
https://pubmed.ncbi.nlm.nih.gov/455244
https://pubmed.ncbi.nlm.nih.gov/455244
Publikováno v:
Lancet (London, England). 1(7864)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7436f3d778a6e9c2f5dfffd9d4177f4
https://pubmed.ncbi.nlm.nih.gov/4133685
https://pubmed.ncbi.nlm.nih.gov/4133685
Autor:
G N, Hortobagyi, J U, Gutterman, G R, Blumenschein, A, Buzdar, M A, Burgess, S P, Richman, C K, Tashima, M, Schwarz, E M, Hersh
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. (62)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a95a6a8b8db302334dd2d157de2cb964
https://pubmed.ncbi.nlm.nih.gov/601328
https://pubmed.ncbi.nlm.nih.gov/601328
Autor:
A U, Buzdar, C K, Tashima, G R, Blumenschein, G N, Hortobagyi, H Y, Yap, A N, Krutchik, G P, Bodey, R B, Livingston
Publikováno v:
Cancer. 41(2)
Fifty patients with breast cancer refractory to endocrine manipulation and/or combination chemotherapy were treated with mitomycin-C 20 mg/m2 I.V. every 4-6 weeks and megestrol acetate 160 mg daily. Of 48 evaluable patients, 4% achieved complete remi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c3b63ce7492fc1b26c8b9af584d1097
https://pubmed.ncbi.nlm.nih.gov/630529
https://pubmed.ncbi.nlm.nih.gov/630529
Autor:
C K, Tashima
Publikováno v:
Lancet (London, England). 2(7880)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::04d85b864fc4b6f03d9192226305531d
https://pubmed.ncbi.nlm.nih.gov/4140297
https://pubmed.ncbi.nlm.nih.gov/4140297
Publikováno v:
Cancer treatment reports. 64(2-3)
In an attempt to improve the therapeutic index of vinblastine by maintaining a prolonged, constant plasma level, it was given as a continuous 5-day infusion at 1.4-2.0 mg/m2/day. Among the 30 evaluable patients with advanced refractory breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc3a0943707edf0dca74a27c59e07e81
https://pubmed.ncbi.nlm.nih.gov/7407762
https://pubmed.ncbi.nlm.nih.gov/7407762